Russia Announces World's First COVID-19 Vaccine, Putin's Daughter Inoculated
Writer: Aditi Tiwari
Journalism is what maintains democracy and I want to be the force for progressive social change. A hardworking and dedicated soul, I strive for new experiences.
Others/World, 11 Aug 2020 9:46 AM GMT | Updated 11 Aug 2020 10:57 AM GMT
Editor : Sumanti Sen |
Sumanti Sen is an English Literature graduate who believes "there's just one kind of folks. Folks.".
Creatives : Abhishek M
" An engineer by profession, Abhishek is the creative producer of the team, graphic designing is his passion and travelling his get away. In more ways than one, he makes the content visually appealing."
Russian President Vladimir Putin has assured of the efficiency of the vaccine by stating that one of his two daughters has received a shot of the vaccine and is stable.
Russia's Gamaleya National Research Centre in partnership with the Russian Defence Ministry has registered the first COVID vaccine in the world. Update in this regard was given by the Russian President Vladimir Putin in a televised video conference call with government ministers.
Putin said: " This morning, for the first time in the world, a vaccine against the new coronavirus was registered."
He has assured of the efficiency of the vaccine by stating that one of his two daughters has received a shot of the vaccine and is stable.
More than 160 vaccine development candidates are in different stages of production with 27 candidates reaching the human trials.
According to the a Times Of India report, Russia's vaccine is an adenovirus based viral vector vaccine which is combined with the spike protein of SARs-COV-2 virus inducing immunity in the body.
The experts had raised a question on the fast track approach of Russia in vaccine development. However, the Director of Gamaleya National Research Centre, Alexander Gintsburg said that it won't harm the body as it does not have multiplying property.
Clinical trials of the vaccine began on June 18 and included 38 volunteers. All of the participants developed immunity. The first group was discharged on July 15 and the second group on July 20.
At present, the global Coronavirus cases have spiked to 20,264,612 with the number of deaths counting to 739,342. Over 12.9 million people have recovered from the disease.
Also Read: Serum Institute Of India Gets DCGI Nod For Phase 2, 3 Trials Of Oxford Vaccine